Deborah M. Sharpe

Deborah M. Sharpe serves as a key procurement professional at the Naval Medical Research Center, supporting the agency’s mission to advance force health protection through biomedical innovation. She manages complex acquisitions for advanced diagnostic systems, laboratory instrumentation, and field-deployable medical technologies critical to operational readiness in austere environments. Her portfolio centers on research and development contracts that translate scientific breakthroughs into deployable capabilities, ensuring Navy and Marine Corps personnel have access to cutting-edge analytical tools and infectious disease detection platforms. Sharpe’s work directly enables the agency’s strategic priorities in rapid diagnostics and precision monitoring for emerging threats. Her primary contractor relationship is with REES SCIENTIFIC CORPORATION, a trusted partner in the development and delivery of specialized laboratory equipment and analytical systems. Sharpe consistently engages this vendor for high-precision instrumentation and custom diagnostic solutions, reflecting a long-standing, performance-driven procurement relationship built on technical alignment and mission-critical delivery timelines. While she maintains a core partnership with REES, her contracting approach remains open to competitive bidding, prioritizing technical capability and compliance over sole-source reliance. Sharpe’s contracting patterns show a strong preference for full and open competition, with 99.5% of awards issued without set-aside restrictions. Small business participation is minimal but intentional, with only 0.5% of awards structured under Total Small Business Set-Asides, indicating a focus on technical merit over socioeconomic preferences. Her approach reflects the specialized nature of the agency’s needs, where mission-critical performance often outweighs socioeconomic targets. Her procurement focus is dominated by NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 541712 (Research and Development in the Physical, Engineering, and Life Sciences), underscoring her expertise in procuring in-vitro diagnostic systems, molecular detection platforms, and advanced laboratory analytics. She routinely acquires custom-engineered equipment for pathogen identification and environmental monitoring, demonstrating deep familiarity with biomedical engineering and field-deployable diagnostic technologies.